Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2021; 11(01): 33-39
DOI: 10.4103/ajm.ajm_110_20
Original Article

Dose adjustment of antidiabetic medications in chronic kidney disease

Matthew Salvatore Snyder
New York Institute of Technology College of Osteopathic Medicine, 101 Northern Boulevard, Old Westbury, NY, USA
,
Joshua Fogel
Department of Business Management, Brooklyn College, 218 Whitehead Hall, Brooklyn, NY, USA
,
Svetlana Pyatigorskaya
Division of Nephrology and Hypertension, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY, USA
,
Sofia Rubinstein
Division of Nephrology and Hypertension, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY, USA
› Author Affiliations
Subject Editor: Financial support and sponsorship Nil.
› Further Information
   Permissions and Reprints

Abstract

Purpose: The purpose of this study is to identify whether Internal Medicine house-staff (IMHS) have awareness and knowledge about the correct dosage of antidiabetic medications for patients with chronic kidney disease (CKD), as dosing errors result in adverse patient outcomes for those with diabetes mellitus (DM) and CKD. Methods: There were 353 IMHS surveyed to evaluate incorrect level of awareness of medication dose adjustment in patients with CKD (ILA) and incorrect level of knowledge of glomerular filtration rate level for medication adjustment (ILK-GFR) for Glipizide, Pioglitazone, and Sitagliptin. Results: Lack of awareness and knowledge was high, with the highest for Pioglitazone at 72.8%. For ILA, the percentages were: Pioglitazone: 72.8%, Glipizide: 43.9%, and Sitagliptin: 42.8%. For ILK-GFR, the percentages were: Pioglitazone: 72.8%, Glipizide: 68.3%, and Sitagliptin: 65.4%. Conclusions: IMHS have poor awareness and knowledge for antidiabetic medication dose adjustment in patients with DM and CKD. Both Electronic Medical Rerecord best practice advisory and physician–pharmacist collaborative drug therapy management can enhance safe drug prescribing in patients with CKD. In addition, IMHS’s practice for antidiabetic medication dose adjustment was better with Nephrology exposure. A formal didactic educational training during medical school and residency for antidiabetic medication dose adjustment in patients with DM and CKD is highly encouraged to prevent medication dosing errors and to more effectively and safely allow IMHS to manage complex treatment regimens.

Keywords

Adult-onset diabetes mellitus - chronic kidney insufficiency - internal medicine - medication error - residency and internship


Publication History

Article published online:
06 August 2021

© 2021. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Centers for Disease Control and Prevention (CDC). National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States. 2019 Available from: https://www.cdc.gov/kidneydisease/pdf/2019_National-Chronic-Kidney-Disease-Fact-Sheet.pdf [Last accessed on 2019 Mar XX]
    PubMedGoogle Scholar
  • 2 Hoerger TJ, Simpson SA, Yarnoff BO, Pavkov ME, Ríos Burrows N, Saydah SH. et al. The future burden of CKD in the United States: A simulation model for the CDC CKD initiative. Am J Kidney Dis 2015; 65: 403-11
    CrossrefPubMedGoogle Scholar
  • 3 Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003; 26: 1408-12
    CrossrefPubMedGoogle Scholar
  • 4 Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C. et al. Appropriate prescribing in elderly people: How well can it be measured and optimised?. Lancet 2007; 370: 173-84
    CrossrefPubMedGoogle Scholar
  • 5 Nyman HA. Renal dosing in high-risk populations. J Infus Nurs 2015; 38: 210-5
    CrossrefPubMedGoogle Scholar
  • 6 Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C. et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function—the three-city population-based study. Nephrol Dial Transplant 2011; 26: 2852-9
    CrossrefPubMedGoogle Scholar
  • 7 Jones RK, Hampton D, O’Sullivan DJ, Phillips AO. Diabetes and renal disease: Who does what?. Clin Med (Lond) 2013; 13: 460-4
    CrossrefPubMedGoogle Scholar
  • 8 Sönnichsen A, Trampisch US, Rieckert A, Piccoliori G, Vögele A, Flamm M. et al. Polypharmacy in chronic diseases-reduction of inappropriate medication and adverse drug events in older populations by electronic decision support (PRIMA-eds): Study protocol for a randomized controlled trial. Trials 2016; 17: 57
    CrossrefPubMedGoogle Scholar
  • 9 Mixon AS, Smith Jr GR, Mallouk M, Nieva HR, Kripalani S, Rennke S. et al MARQUIS2 Site Leaders; MARQUIS2 Study Group. Design of MARQUIS2: Study protocol for a mentored implementation study of an evidence-based toolkit to improve patient safety through medication reconciliation. BMC Health Serv Res 2019; 19: 659
    CrossrefPubMedGoogle Scholar
  • 10 Physicians’ Desk Reference. 71st ed. Montvale, NJ: PDR Network, LLC; 2017
    Google Scholar
  • 11 Decloedt E, Leisegang R, Blockman M, Cohen K. Dosage adjustment in medical patients with renal impairment at groote schuur hospital. S Afr Med J 2010; 100: 304-6
    CrossrefPubMedGoogle Scholar
  • 12 van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 2006; 40: 1254-60
    CrossrefPubMedGoogle Scholar
  • 13 Hashmi A. Pioglitazone suspension and its aftermath: A wake up call for the Indian drug regulatory authorities. J Pharmacol Pharmacother 2013; 4: 227-9
    CrossrefPubMedGoogle Scholar
  • 14 Cefalu WT. American Diabetes Association standards of medical care in diabetes-2016. Diabetes Care 2016; 39 Suppl (01) S52-9
    CrossrefPubMedGoogle Scholar
  • 15 Institute for Clinical and Economic Review. Controversies in the management of patients with type 2 diabetes. Boston, MA: Institute for Clinical & Economical Review; 2014. Available from: https://icer-review.org/wp-content/uploads/2015/03/CEPAC-T2D-Final-Report-December-22.pdf [Last accessed on 2018 Feb XX]
    Google Scholar
  • 16 Schramm J, Andersen M, Vach K, Kragstrup J, Kampmann JP, Søndergaard J. Promotional methods used by representatives of drug companies: A prospective survey in general practice. Scand J Prim Health Care 2007; 25: 93-7
    CrossrefPubMedGoogle Scholar
  • 17 Agrawal V, Ghosh AK, Barnes MA, McCullough PA. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: A national online survey. Am J Kidney Dis 2008; 52: 1061-9
    CrossrefPubMedGoogle Scholar
  • 18 Akbar SR, Iqbal HI, Ahmed U. The need to emphasize nephrology knowledge in residents-in-training. N Am J Med Sci 2015; 7: 524-8
    CrossrefPubMedGoogle Scholar
  • 19 Sperati CJ, Soman S, Agrawal V, Liu Y, Abdel-Kader K, Diamantidis CJ. et al National Kidney Foundation Education Committee. Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study. PLoS One 2019; 14: e0221325
    CrossrefPubMedGoogle Scholar
  • 20 Agrawal V, Jhaveri KD, Shah HH. Enhancing outpatient nephrology experience for internal medicine residents. Clin Kidney J 2017; 10: 429-36
    CrossrefPubMedGoogle Scholar
  • 21 O’Donnell A, Kaner E, Shaw C, Haighton C. Primary care physicians’ attitudes to the adoption of electronic medical records: A systematic review and evidence synthesis using the clinical adoption framework. BMC Med Inform Decis Mak 2018; 18: 101
    CrossrefPubMedGoogle Scholar
  • 22 Villalba-Mora E, Casas I, Lupiañez-Villanueva F, Maghiros I. Adoption of health information technologies by physicians for clinical practice: The andalusian case. Int J Med Inform 2015; 84: 477-85
    CrossrefPubMedGoogle Scholar
  • 23 Shachak A, Hadas-Dayagi M, Ziv A, Reis S. Primary care physicians’ use of an electronic medical record system: A cognitive task analysis. J Gen Intern Med 2009; 24: 341-8
    CrossrefPubMedGoogle Scholar
  • 24 Awdishu L, Singh RF, Saunders I, Yam FK, Hirsch JD, Lorentz S. et al. Advancing Pharmacist Collaborative Care within Academic Health Systems. Pharmacy (Basel) 2019; 7: 142
    CrossrefPubMedGoogle Scholar
  • 25 Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization. Am J Health Syst Pharm 2018; 75: 1039-47
    CrossrefPubMedGoogle Scholar
  • 26 Accreditation Council for Graduate Medical Education. ACGME data resource book academic year 2015–2016. Chicago, IL: Accreditation Council for Graduate Medical Education; 2017
    Google Scholar
  • 27 Ash JS, Sittig DF, Guappone KP, Dykstra RH, Richardson J, Wright A. et al. Recommended practices for computerized clinical decision support and knowledge management in community settings: A qualitative study. BMC Med Inform Decis Mak 2012; 12: 6
    CrossrefPubMedGoogle Scholar